LINCOLN PHARMACEUTICALS
|
The Current P/B Ratio of LINCOLN PHARMACEUTICALS is 2.41.
Share Price | ₹604.7 | Apr 30,2024 |
Market Cap | ₹1,209.3 Cr | |
Book Value | ₹502.5 Cr | Mar2023 - Consolidated Results |
Price/Book | 2.41x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of LINCOLN PHARMACEUTICALS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹1,209.3 Cr] as on Apr 30,2024
(/) Book Value [ ₹502.5 Cr] based on Mar2023 - Consolidated Results
(=) P/B Ratio [ 2.41x ]
Thus, for LINCOLN PHARMACEUTICALS , the investors are currently willing to pay '2.41 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of LINCOLN PHARMACEUTICALS !
The chart below summarizes the trend in P/B Ratio of LINCOLN PHARMACEUTICALS over the last five years.
Historical PB (Price/Book ) ratio chart of LINCOLN PHARMACEUTICALS
PB Ratio Performance Analysis for LINCOLN PHARMACEUTICALS
- LINCOLN PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.29x.
- LINCOLN PHARMACEUTICALS 's operated at median p/b ratio of 1.35x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LINCOLN PHARMACEUTICALS 's p/b ratio peaked in Mar2019 at 1.58x.
- LINCOLN PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2020 of 0.85x.
How does LINCOLN PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
LINCOLN PHARMACEUTICALS | 502.48 | 2.41 | 1,209.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.44 | 360,452.0 |
CIPLA LTD | 23,346.00 | 4.85 | 113,132.0 |
DR REDDYS LABORATORIES LTD | 23,140.40 | 4.47 | 103,512.0 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.48 | 95,954.5 |
DIVIS LABORATORIES LTD | 12,767.10 | 8.32 | 106,191.0 |
MANKIND PHARMA LTD | 7,435.16 | 12.75 | 94,779.2 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 14.42 | 89,363.1 |
LUPIN LTD | 12,315.60 | 6.09 | 74,991.4 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.52 | 67,526.5 |
ABBOTT INDIA LTD | 3,146.02 | 17.84 | 56,131.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs LINCOLN PHARMACEUTICALS 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.41x |
Max industry PB | 17.84x |
Median industry PB | 6.09x |
Average industry PB | 7.78x |
You may also like the below Video Courses